EU making progress in AMR via research, regulatory efforts
LONDON Amongst all the talk, the reports and the policy initiatives, there is a palpable sense that Europe is starting to make some headway in the practicalities of dealing with the threat of antimicrobial resistance (AMR).
Will innovation pay the price for med-tech biggering?
The urge to go on biggering and biggering and biggering has taken over the med-tech world. Barely a year after Zimmer and Biomet completed a $14 billion merger to become the second largest orthopedic device maker, the company now plans to spend another $1 billion to buy LDR and grow its spine business. (MDD Perspectives)
Closing of $175M Asia VC fund underlines core opportunities in the medical device space
HONG KONG In the midst of technological advancements that are disrupting the traditional health technology industry, some venture capital (VC) funds are reaping significant benefits by jumping into the medical device space in Asia in the formative days of the companies.